Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in children and adults ID1297Product type:GuidanceProgramme:Technology appraisal guidanceExpected publication date: 28 July 2021
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)Product type:GuidanceProgramme:Highly specialised technologies guidanceLast updated: 20 September 2024Published: 10 October 2018
Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal) (TA982)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 June 2024
Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over (TA977)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 May 2024
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and under (TA975)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 May 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal) (TA945)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 January 2024
Risdiplam for treating spinal muscular atrophy (TA755)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 15 December 2023Published: 16 December 2021
Transient loss of consciousness ('blackouts') in over 16s (CG109)Product type:GuidanceProgramme:Clinical guidelineLast updated: 21 November 2023Published: 25 August 2010
Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 23 June 2015
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment (HTE3)Product type:GuidanceProgramme:Health technology evaluationLast updated: 5 September 2023Published: 8 February 2023
Otitis media with effusion in under 12s (NG233)Product type:GuidanceProgramme:NICE guidelinePublished: 30 August 2023
Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal) (TA910)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2023
Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young people (IPG765)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2023
Atopic eczema in under 12s: diagnosis and management (CG57)Product type:GuidanceProgramme:Clinical guidelineLast updated: 7 June 2023Published: 12 December 2007
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 May 2023Published: 1 August 2015
Asfotase alfa for treating paediatric-onset hypophosphatasia (HST23)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 1 March 2023
Somatrogon for treating growth disturbance in children and young people aged 3 years and over (TA863)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 February 2023
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education (NG213)Product type:GuidanceProgramme:NICE guidelineLast updated: 13 January 2023Published: 9 March 2022
Self-harm: assessment, management and preventing recurrence (NG225)Product type:GuidanceProgramme:NICE guidelinePublished: 7 September 2022
Urinary tract infection in under 16s: diagnosis and management (NG224)Product type:GuidanceProgramme:NICE guidelinePublished: 27 July 2022
Fenfluramine for treating seizures associated with Dravet syndrome (TA808)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 July 2022
Social, emotional and mental wellbeing in primary and secondary education (NG223)Product type:GuidanceProgramme:NICE guidelinePublished: 6 July 2022
Vertebral body tethering for idiopathic scoliosis in children and young people (IPG728)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 29 June 2022
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over (HST20)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 5 May 2022
Epilepsies in children, young people and adults (NG217)Product type:GuidanceProgramme:NICE guidelinePublished: 27 April 2022
Atidarsagene autotemcel for treating metachromatic leukodystrophy (HST18)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 28 March 2022
Palforzia for treating peanut allergy in children and young people (TA769)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 2 February 2022
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) (TA749)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 December 2021
Fever in under 5s: assessment and initial management (NG143)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 November 2021Published: 7 November 2019
Looked-after children and young people (NG205)Product type:GuidanceProgramme:NICE guidelinePublished: 20 October 2021
Secukinumab for treating moderate to severe plaque psoriasis in children and young people (TA734)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 7 October 2021
Babies, children and young people's experience of healthcare (NG204)Product type:GuidanceProgramme:NICE guidelinePublished: 25 August 2021
Bronchiolitis in children: diagnosis and management (NG9)Product type:GuidanceProgramme:NICE guidelineLast updated: 9 August 2021Published: 1 June 2015
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal) (TA714)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 July 2021
Autism spectrum disorder in under 19s: support and management (CG170)Product type:GuidanceProgramme:Clinical guidelineLast updated: 14 June 2021Published: 28 August 2013
Asthma: diagnosis, monitoring and chronic asthma management (NG80)Product type:GuidanceProgramme:NICE guidelineLast updated: 22 March 2021Published: 29 November 2017
Cannabis-based medicinal products (NG144)Product type:GuidanceProgramme:NICE guidelineLast updated: 22 March 2021Published: 11 November 2019
Eating disorders: recognition and treatment (NG69)Product type:GuidanceProgramme:NICE guidelineLast updated: 16 December 2020Published: 23 May 2017
Intravenous fluid therapy in children and young people in hospital (NG29)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 June 2020Published: 9 December 2015
Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 December 2019
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome (TA615)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 December 2019
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 27 November 2019
Gastro-oesophageal reflux disease in children and young people: diagnosis and management (NG1)Product type:GuidanceProgramme:NICE guidelineLast updated: 9 October 2019Published: 14 January 2015
Attention deficit hyperactivity disorder: diagnosis and management (NG87)Product type:GuidanceProgramme:NICE guidelineLast updated: 13 September 2019Published: 14 March 2018
End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)Product type:GuidanceProgramme:NICE guidelineLast updated: 25 July 2019Published: 7 December 2016
Depression in children and young people: identification and management (NG134)Product type:GuidanceProgramme:NICE guidelinePublished: 25 June 2019
Cochlear implants for children and adults with severe to profound deafness (TA566)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 7 March 2019
Cough (acute): antimicrobial prescribing (NG120)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2019
Dinutuximab beta for treating neuroblastoma (TA538)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 August 2018
Learning disabilities and behaviour that challenges: service design and delivery (NG93)Product type:GuidanceProgramme:NICE guidelinePublished: 28 March 2018
Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)Product type:GuidanceProgramme:Clinical guidelineLast updated: 20 December 2017Published: 28 September 2011
Immunosuppressive therapy for kidney transplant in children and young people (TA482)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 October 2017
Child maltreatment: when to suspect maltreatment in under 18s (CG89)Product type:GuidanceProgramme:Clinical guidelineLast updated: 9 October 2017Published: 22 July 2009
Faltering growth: recognition and management of faltering growth in children (NG75)Product type:GuidanceProgramme:NICE guidelinePublished: 27 September 2017
Developmental follow-up of children and young people born preterm (NG72)Product type:GuidanceProgramme:NICE guidelinePublished: 9 August 2017
Constipation in children and young people: diagnosis and management (CG99)Product type:GuidanceProgramme:Clinical guidelineLast updated: 13 July 2017Published: 26 May 2010
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (TA455)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 July 2017
Antisocial behaviour and conduct disorders in children and young people: recognition and management (CG158)Product type:GuidanceProgramme:Clinical guidelineLast updated: 19 April 2017Published: 27 March 2013
Cerebral palsy in under 25s: assessment and management (NG62)Product type:GuidanceProgramme:NICE guidelinePublished: 25 January 2017
Spasticity in under 19s: management (CG145)Product type:GuidanceProgramme:Clinical guidelineLast updated: 29 November 2016Published: 25 July 2012
Psychosis and schizophrenia in children and young people: recognition and management (CG155)Product type:GuidanceProgramme:Clinical guidelineLast updated: 26 October 2016Published: 23 January 2013
Harmful sexual behaviour among children and young people (NG55)Product type:GuidanceProgramme:NICE guidelinePublished: 20 September 2016
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64)Product type:GuidanceProgramme:Clinical guidelineLast updated: 8 July 2016Published: 17 March 2008
Transition from children’s to adults’ services for young people using health or social care services (NG43)Product type:GuidanceProgramme:NICE guidelinePublished: 24 February 2016
Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care (NG26)Product type:GuidanceProgramme:NICE guidelinePublished: 25 November 2015
Maternal and child nutrition (PH11)Product type:GuidanceProgramme:Public health guidelineLast updated: 1 November 2014Published: 26 March 2008
Contraceptive services for under 25s (PH51)Product type:GuidanceProgramme:Public health guidelinePublished: 26 March 2014
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal) (TA302)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 November 2013
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (TA300)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 November 2013
Weight management: lifestyle services for overweight or obese children and young people (PH47)Product type:GuidanceProgramme:Public health guidelinePublished: 23 October 2013
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder (TA292)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2013
Social and emotional wellbeing: early years (PH40)Product type:GuidanceProgramme:Public health guidelinePublished: 24 October 2012
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis (TA238)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2011
Food allergy in under 19s: assessment and diagnosis (CG116)Product type:GuidanceProgramme:Clinical guidelinePublished: 23 February 2011
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (TA213)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 January 2011
Sedation in under 19s: using sedation for diagnostic and therapeutic procedures (CG112)Product type:GuidanceProgramme:Clinical guidelinePublished: 15 December 2010
Unintentional injuries in the home: interventions for under 15s (PH30)Product type:GuidanceProgramme:Public health guidelinePublished: 24 November 2010
Unintentional injuries on the road: interventions for under 15s (PH31)Product type:GuidanceProgramme:Public health guidelinePublished: 24 November 2010
Unintentional injuries: prevention strategies for under 15s (PH29)Product type:GuidanceProgramme:Public health guidelinePublished: 24 November 2010
Bedwetting in under 19s (CG111)Product type:GuidanceProgramme:Clinical guidelinePublished: 27 October 2010
Human growth hormone (somatropin) for the treatment of growth failure in children (TA188)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 May 2010
Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management (CG84)Product type:GuidanceProgramme:Clinical guidelinePublished: 22 April 2009
Physical activity for children and young people (PH17)Product type:GuidanceProgramme:Public health guidelinePublished: 28 January 2009
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years (TA131)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 November 2007
Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children (IPG232)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 September 2007
Improving outcomes in children and young people with cancer (CSG7)Product type:GuidanceProgramme:Cancer service guidelinePublished: 24 August 2005
Balloon dilatation of systemic to pulmonary arterial shunts in children (IPG77)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 July 2004
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children (IPG76)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 July 2004
Vagus nerve stimulation for refractory epilepsy in children (IPG50)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 March 2004
Inhaler devices for routine treatment of chronic asthma in older children (aged 5 to 15 years) (TA38)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2002
Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma (TA10)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 August 2000
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children (MIB163)Product type:AdviceProgramme:Medtech innovation briefingPublished: 26 October 2018
Next-generation sequencing panel for solid tumour cancers in children (MIB133)Product type:AdviceProgramme:Medtech innovation briefingPublished: 8 January 2018
Thora-3Di for assessing asthma in children (MIB122)Product type:AdviceProgramme:Medtech innovation briefingPublished: 2 October 2017
Mitochondrial disorders in children: Co-enzyme Q10 (ES11)Product type:AdviceProgramme:Evidence summaryPublished: 28 March 2017
Mollii suit for spasticity (MIB100)Product type:AdviceProgramme:Medtech innovation briefingPublished: 28 March 2017
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide (ES5)Product type:AdviceProgramme:Evidence summaryPublished: 14 February 2017
Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)Product type:AdviceProgramme:Evidence summaryPublished: 7 October 2014
Promoting tolerance of enteral feeds in children and young people: domperidone (ESUOM18)Product type:AdviceProgramme:Evidence summaryLast updated: 30 September 2014Published: 30 July 2013
Transition from children’s to adults’ services (QS140)Product type:Quality standardLast updated: 14 December 2023Published: 21 December 2016
Fever in under 5s (QS64)Product type:Quality standardLast updated: 27 July 2022Published: 24 July 2014
Urinary tract infection in children and young people (QS36)Product type:Quality standardLast updated: 27 July 2022Published: 16 July 2013
Vaccine uptake in under 19s (QS145)Product type:Quality standardLast updated: 17 May 2022Published: 2 March 2017
Diabetes in children and young people (QS125)Product type:Quality standardLast updated: 31 March 2022Published: 14 July 2016
Developmental follow-up of children and young people born preterm (QS169)Product type:Quality standardPublished: 18 May 2018
Suspected cancer (QS124)Product type:Quality standardLast updated: 5 December 2017Published: 30 June 2016
Cerebral palsy in children and young people (QS162)Product type:Quality standardPublished: 10 October 2017
End of life care for infants, children and young people (QS160)Product type:Quality standardPublished: 12 September 2017
Intravenous fluid therapy in children and young people in hospital (QS131)Product type:Quality standardPublished: 21 September 2016
Early years: promoting health and wellbeing in under 5s (QS128)Product type:Quality standardPublished: 11 August 2016
Obesity: clinical assessment and management (QS127)Product type:Quality standardPublished: 4 August 2016
Gastro-oesophageal reflux in children and young people (QS112)Product type:Quality standardPublished: 28 January 2016
Preventing unintentional injury in under 15s (QS107)Product type:Quality standardPublished: 14 January 2016
Bipolar disorder, psychosis and schizophrenia in children and young people (QS102)Product type:Quality standardPublished: 15 October 2015
Obesity in children and young people: prevention and lifestyle weight management programmes (QS94)Product type:Quality standardPublished: 23 July 2015
Nutrition: improving maternal and child nutrition (QS98)Product type:Quality standardPublished: 1 July 2015
Bedwetting in children and young people (QS70)Product type:Quality standardPublished: 18 September 2014
Antisocial behaviour and conduct disorders in children and young people (QS59)Product type:Quality standardPublished: 17 April 2014
Cancer services for children and young people (QS55)Product type:Quality standardPublished: 27 February 2014
Depression in children and young people (QS48)Product type:Quality standardPublished: 30 September 2013